About Us Services Careers FAQ Contact Us 0
Home Medical Devices Neurology Clinical Trials Market Growth Trends and Competitive Analysis 2030
Neurology Clinical Trials Market

Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRMD2946DR
Last Updated : Oct 17, 2022
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Neurology Clinical Trials Market, By Phase (2020-2030)
    1. Phase I
    2. Phase II
    3. Phase III
    4. Phase IV
  2. Neurology Clinical Trials Market, By Study Design (2020-2030)
    1. Interventional
    2. Observational
    3. Expanded Access
  3. Neurology Clinical Trials Market, By Indication (2020-2030)
    1. Epilepsy
    2. Parkinson's Disease (PD)
    3. Huntington's Disease
    4. Stroke
    5. Traumatic Brain Injury (TBI)
    6. Amyotrophic Lateral Sclerosis (ALS)
    7. Muscle regeneration
    8. Others
    1. North America
      1. North America Neurology Clinical Trials Market, By Phase
        1. Phase I
          1. Phase II
            1. Phase III
              1. Phase IV
              2. North America Neurology Clinical Trials Market, By Study Design
                1. Interventional
                  1. Observational
                    1. Expanded Access
                    2. North America Neurology Clinical Trials Market, By Indication
                      1. Epilepsy
                        1. Parkinson's Disease (PD)
                          1. Huntington's Disease
                            1. Stroke
                              1. Traumatic Brain Injury (TBI)
                                1. Amyotrophic Lateral Sclerosis (ALS)
                                  1. Muscle regeneration
                                    1. Others
                                    2. U.S.
                                      1. U.S. Neurology Clinical Trials Market, By Phase
                                        1. Phase I
                                          1. Phase II
                                            1. Phase III
                                              1. Phase IV
                                              2. U.S. Neurology Clinical Trials Market, By Study Design
                                                1. Interventional
                                                  1. Observational
                                                    1. Expanded Access
                                                    2. U.S. Neurology Clinical Trials Market, By Indication
                                                      1. Epilepsy
                                                        1. Parkinson's Disease (PD)
                                                          1. Huntington's Disease
                                                            1. Stroke
                                                              1. Traumatic Brain Injury (TBI)
                                                                1. Amyotrophic Lateral Sclerosis (ALS)
                                                                  1. Muscle regeneration
                                                                    1. Others
                                                                  2. Canada
                                                                2. Europe
                                                                  1. Europe Neurology Clinical Trials Market, By Phase
                                                                    1. Phase I
                                                                      1. Phase II
                                                                        1. Phase III
                                                                          1. Phase IV
                                                                          2. Europe Neurology Clinical Trials Market, By Study Design
                                                                            1. Interventional
                                                                              1. Observational
                                                                                1. Expanded Access
                                                                                2. Europe Neurology Clinical Trials Market, By Indication
                                                                                  1. Epilepsy
                                                                                    1. Parkinson's Disease (PD)
                                                                                      1. Huntington's Disease
                                                                                        1. Stroke
                                                                                          1. Traumatic Brain Injury (TBI)
                                                                                            1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                              1. Muscle regeneration
                                                                                                1. Others
                                                                                                2. U.K.
                                                                                                  1. U.K. Neurology Clinical Trials Market, By Phase
                                                                                                    1. Phase I
                                                                                                      1. Phase II
                                                                                                        1. Phase III
                                                                                                          1. Phase IV
                                                                                                          2. U.K. Neurology Clinical Trials Market, By Study Design
                                                                                                            1. Interventional
                                                                                                              1. Observational
                                                                                                                1. Expanded Access
                                                                                                                2. U.K. Neurology Clinical Trials Market, By Indication
                                                                                                                  1. Epilepsy
                                                                                                                    1. Parkinson's Disease (PD)
                                                                                                                      1. Huntington's Disease
                                                                                                                        1. Stroke
                                                                                                                          1. Traumatic Brain Injury (TBI)
                                                                                                                            1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                              1. Muscle regeneration
                                                                                                                                1. Others
                                                                                                                              2. Germany
                                                                                                                              3. France
                                                                                                                              4. Spain
                                                                                                                              5. Italy
                                                                                                                              6. Russia
                                                                                                                              7. Nordic
                                                                                                                              8. Benelux
                                                                                                                              9. Rest of Europe
                                                                                                                            2. APAC
                                                                                                                              1. APAC Neurology Clinical Trials Market, By Phase
                                                                                                                                1. Phase I
                                                                                                                                  1. Phase II
                                                                                                                                    1. Phase III
                                                                                                                                      1. Phase IV
                                                                                                                                      2. APAC Neurology Clinical Trials Market, By Study Design
                                                                                                                                        1. Interventional
                                                                                                                                          1. Observational
                                                                                                                                            1. Expanded Access
                                                                                                                                            2. APAC Neurology Clinical Trials Market, By Indication
                                                                                                                                              1. Epilepsy
                                                                                                                                                1. Parkinson's Disease (PD)
                                                                                                                                                  1. Huntington's Disease
                                                                                                                                                    1. Stroke
                                                                                                                                                      1. Traumatic Brain Injury (TBI)
                                                                                                                                                        1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                          1. Muscle regeneration
                                                                                                                                                            1. Others
                                                                                                                                                            2. China
                                                                                                                                                              1. China Neurology Clinical Trials Market, By Phase
                                                                                                                                                                1. Phase I
                                                                                                                                                                  1. Phase II
                                                                                                                                                                    1. Phase III
                                                                                                                                                                      1. Phase IV
                                                                                                                                                                      2. China Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                        1. Interventional
                                                                                                                                                                          1. Observational
                                                                                                                                                                            1. Expanded Access
                                                                                                                                                                            2. China Neurology Clinical Trials Market, By Indication
                                                                                                                                                                              1. Epilepsy
                                                                                                                                                                                1. Parkinson's Disease (PD)
                                                                                                                                                                                  1. Huntington's Disease
                                                                                                                                                                                    1. Stroke
                                                                                                                                                                                      1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                        1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                          1. Muscle regeneration
                                                                                                                                                                                            1. Others
                                                                                                                                                                                          2. Korea
                                                                                                                                                                                          3. Japan
                                                                                                                                                                                          4. India
                                                                                                                                                                                          5. Australia
                                                                                                                                                                                          6. Taiwan
                                                                                                                                                                                          7. South East Asia
                                                                                                                                                                                          8. Rest of Asia-Pacific
                                                                                                                                                                                        2. Middle East and Africa
                                                                                                                                                                                          1. Middle East and Africa Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                            1. Phase I
                                                                                                                                                                                              1. Phase II
                                                                                                                                                                                                1. Phase III
                                                                                                                                                                                                  1. Phase IV
                                                                                                                                                                                                  2. Middle East and Africa Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                    1. Interventional
                                                                                                                                                                                                      1. Observational
                                                                                                                                                                                                        1. Expanded Access
                                                                                                                                                                                                        2. Middle East and Africa Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                          1. Epilepsy
                                                                                                                                                                                                            1. Parkinson's Disease (PD)
                                                                                                                                                                                                              1. Huntington's Disease
                                                                                                                                                                                                                1. Stroke
                                                                                                                                                                                                                  1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                    1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                      1. Muscle regeneration
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                        2. UAE
                                                                                                                                                                                                                          1. UAE Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                                                            1. Phase I
                                                                                                                                                                                                                              1. Phase II
                                                                                                                                                                                                                                1. Phase III
                                                                                                                                                                                                                                  1. Phase IV
                                                                                                                                                                                                                                  2. UAE Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                                                    1. Interventional
                                                                                                                                                                                                                                      1. Observational
                                                                                                                                                                                                                                        1. Expanded Access
                                                                                                                                                                                                                                        2. UAE Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                                                          1. Epilepsy
                                                                                                                                                                                                                                            1. Parkinson's Disease (PD)
                                                                                                                                                                                                                                              1. Huntington's Disease
                                                                                                                                                                                                                                                1. Stroke
                                                                                                                                                                                                                                                  1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                                                    1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                                                      1. Muscle regeneration
                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                      1. LATAM Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                                                                                        1. Phase I
                                                                                                                                                                                                                                                          1. Phase II
                                                                                                                                                                                                                                                            1. Phase III
                                                                                                                                                                                                                                                              1. Phase IV
                                                                                                                                                                                                                                                              2. LATAM Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                                                                                1. Interventional
                                                                                                                                                                                                                                                                  1. Observational
                                                                                                                                                                                                                                                                    1. Expanded Access
                                                                                                                                                                                                                                                                    2. LATAM Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                                                                                      1. Epilepsy
                                                                                                                                                                                                                                                                        1. Parkinson's Disease (PD)
                                                                                                                                                                                                                                                                          1. Huntington's Disease
                                                                                                                                                                                                                                                                            1. Stroke
                                                                                                                                                                                                                                                                              1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                                                                                1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                                                                                  1. Muscle regeneration
                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                    2. Brazil
                                                                                                                                                                                                                                                                                      1. Brazil Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                                                                                                                        1. Phase I
                                                                                                                                                                                                                                                                                          1. Phase II
                                                                                                                                                                                                                                                                                            1. Phase III
                                                                                                                                                                                                                                                                                              1. Phase IV
                                                                                                                                                                                                                                                                                              2. Brazil Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                                                                                                                1. Interventional
                                                                                                                                                                                                                                                                                                  1. Observational
                                                                                                                                                                                                                                                                                                    1. Expanded Access
                                                                                                                                                                                                                                                                                                    2. Brazil Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                                                                                                                      1. Epilepsy
                                                                                                                                                                                                                                                                                                        1. Parkinson's Disease (PD)
                                                                                                                                                                                                                                                                                                          1. Huntington's Disease
                                                                                                                                                                                                                                                                                                            1. Stroke
                                                                                                                                                                                                                                                                                                              1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                                                                                                                1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                                                                                                                  1. Muscle regeneration
                                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                                                                                                              Related Reports

                                                                                                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                                                                                                              Market OverviewThe global pediatric clinical trials market size was valued at USD 15.87 billion in 2023 and it is projected to reach at USD 25.13 billion by 2032, increasing at a CAGR of 6.2% from 2024 to 2032. For a variety of indications that
                                                                                                                                                                                                                                                                                                              Buy Now

                                                                                                                                                                                                                                                                                                              Purchase Benefits

                                                                                                                                                                                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                              • Completely customizable scope
                                                                                                                                                                                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                              • Dedicated account manager
                                                                                                                                                                                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                              • Permission to print the report

                                                                                                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                                                                                                              www.straitsresearch.com
                                                                                                                                                                                                                                                                                                              © Copyright . All rights Reserved.